How big a factor should racial equity be in deciding how to distribute the COVID-19 vaccine?

{ object.primary_image.title }}

Minority groups have been disproportionately affected by the coronavirus. Should they be prioritized when we’re distributing the vaccine? As Oxford University’s vaccine entered its final trial phase, and experts noted that the vaccine could appear before the end of the year, the chair of the U.K.’s COVID-19 task force, Kate Bingham, appeared on a national morning show last week to announce preliminary recommendations from the country’s Joint Committee on Vaccination and Immunisation. She announced that the independent group had recommended to the government to prioritize four groups for a vaccine: people over 50, people with additional health conditions, front-line workers—and ethnic minorities. Read Full Story

Read Full Article on Fast Company

How Facebook can make up for disinformation and help get everyone vaccinated for COVID-19

{ object.primary_image.title }}

Ads targeted to zip codes where vaccine uptake is low could have positive results. Facebook should give them away to public health departments. With the first vaccines administered in the U.S., the end of the COVID-19 pandemic is now in sight. The challenge over the next year will be achieving widespread vaccination across the entire population, especially among people of color who are suffering and dying from the virus at higher rates . Many experts are worried that vaccination rates for minority groups could lag behind the rest of the population. Data from the first weeks of the vaccine rollout indicate that in some states, white Americans are being vaccinated at two to three times the rate of Black Americans. Read Full Story

More

No internet, no vaccine: How lack of internet has limited vaccine access for racial minorities

{ object.primary_image.title }}

Three researchers who study health disparities are seeing increasing evidence that a lack of internet access is preventing people in racial and ethnic minority groups from getting vaccines. Racial and ethnic minority communities that lack internet access have been left behind in the race to get a COVID-19 vaccine. The average monthly cost of internet access, about $70 , can be out of reach for those who can barely afford groceries. Read Full Story

More

COVID-19 vaccine distribution: 5 maps that show how we can get them to everyone

{ object.primary_image.title }}

Distribution of the COVID-19 vaccines will create unprecedented logistical challenges for state and local governments. The ultra-rapid development of multiple COVID-19 vaccines over the last few months has been nothing short of amazing, but these life-saving, economy-rescuing, normal-world-restoring treatments won’t mean a whole lot unless we can actually get them to people. Distribution will have to happen on an unprecedented scale, which presents unprecedented logistical challenges for state and local governments. Read Full Story

More

Who should get a COVID-19 vaccine first? It’s complicated

{ object.primary_image.title }}

Scientists are modeling out what happens when you prioritize vaccinating different demographic groups to understand what an optimal rollout looks like. I f the book of nature is written in the language of mathematics, as Galileo once declared, the COVID-19 pandemic has brought that truth home for the world’s mathematicians, who have been galvanized by the rapid spread of the coronavirus. Read Full Story

More

This COVID-19 vaccine distribution tracker lets you see where the doses are going

{ object.primary_image.title }}

As you wait for a vaccine, you can check out the CDC’s database to see how well your state is progressing. The rollout of the COVID-19 vaccines has been frustratingly slow, so much so that some health professionals are now considering the potential benefits of delaying the second part of the two-dose vaccine in the interest giving more people the their first shot quicker. Read Full Story

More

This company is preparing to manufacture 100 million doses of COVID-19 vaccines

{ object.primary_image.title }}

The pharmaceutical company Sanofi is retrofitting current manufacturing facilities so they’ll be able to pump out millions of COVID-19 vaccine doses when it is finally developed. There are 76 vaccine candidates for COVID-19, five of which are in clinical trials. It will take at least 18 months to determine if these vaccines are effective and safe enough to distribute en masse. Then, distributing them to millions of people will require an incredible feat of manufacturing. Read Full Story

More

How to distribute the COVID-19 vaccine: Lessons from Amazon and Walmart

{ object.primary_image.title }}

Supply-chain ideas practiced by Amazon and Walmart can help reduce waste and minimize shortages of COVID-19 vaccines. The initial rollout of Pfizer’s COVID-19 vaccine has begun, and vaccines are shipping across the U.S. Demand for COVID-19 vaccines will outpace supply for the foreseeable future. Yet experts have warned that a substantial proportion of these highly perishable vaccines could go to waste if they are not being used before they expire. Read Full Story

More

Subscribe to our newsletter

Join our newsletter and never miss out trending marketing news.

HitcountVariables(pk=6523, ajax_url='/api/hit/ajax/', hits='9')